Protective Effects of Monoclonal Antibodies against Parainfluenza Virus Type 3-induced Brain Infection in Hamsters
- 1 May 1988
- journal article
- research article
- Published by Microbiology Society in Journal of General Virology
- Vol. 69 (5) , 1019-1024
- https://doi.org/10.1099/0022-1317-69-5-1019
Abstract
A collection of monoclonal antibodies (MAbs) against the haemagglutinin-neuraminidase (HN) and fusion (F) glycoproteins of parainfluenza virus type 3 (PIV3) was used for passive immunization of intracerebrally infected newborn hamsters. A significant degree of protection was obtained with MAbs against both the HN and F viral proteins, but no individual antibody conferred complete protection against disease. MAbs against different epitopes provided different degrees of protection. A MAb to the Sendai virus HN protein was found to confer protection against PIV3 brain infection.This publication has 21 references indexed in Scilit:
- Experimental parainfluenza virus infection in mice: Growth and spread of a highly pathogenic variant of parainfluenza 3 virus in the mouse brainArchiv für die gesamte Virusforschung, 1985
- Protection against lethal viral infection by neutralizing and nonneutralizing monoclonal antibodies: distinct mechanisms of action in vivoJournal of Virology, 1984
- Protein Subunit Vaccines of Parainfluenza Type 3 Virus: Immunogenic Effect in Lambs and MiceJournal of General Virology, 1983
- The effects of monoclonal antibodies on biologic activities of structural proteins of Sendai virus.The Journal of Immunology, 1982
- Delineation of four antigenic sites on a paramyxovirus glycoprotein via which monoclonal antibodies mediate distinct antiviral activities.The Journal of Immunology, 1982
- Induction of subacute murine measles encephalitis by monoclonal antibody to virus haemagglutininNature, 1981
- Persistent parainfluenza virus shedding during isolation at the South PoleNature, 1981
- ParamyxoviridaeIntervirology, 1978
- Altered reactivity to measles virus. Atypical measles in children previously immunized with inactivated measles virus vaccinesJAMA, 1967
- Newly Recognized Myxoviruses from Children with Respiratory DiseaseNew England Journal of Medicine, 1958